Uber Technologies R&D increased by 7.5% to $951.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $815.00M to $951.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 13.4% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $488.00M | $493.00M | $558.00M | $587.00M | $704.00M | $760.00M | $747.00M | $775.00M | $808.00M | $797.00M | $784.00M | $790.00M | $760.00M | $774.00M | $785.00M | $815.00M | $840.00M | $862.00M | $885.00M | $951.00M |
| QoQ Change | — | +1.0% | +13.2% | +5.2% | +19.9% | +8.0% | -1.7% | +3.7% | +4.3% | -1.4% | -1.6% | +0.8% | -3.8% | +1.8% | +1.4% | +3.8% | +3.1% | +2.6% | +2.7% | +7.5% |
| YoY Change | — | — | — | — | +44.3% | +54.2% | +33.9% | +32.0% | +14.8% | +4.9% | +5.0% | +1.9% | -5.9% | -2.9% | +0.1% | +3.2% | +10.5% | +11.4% | +12.7% | +16.7% |